Novel BRCA1 Mutation in Non-Ashkenazi Jews with Ovarian Cancer
Author Information
Author(s): L Theodor, R Bar-Sade, A Kruglikova, G Ben-Baruch, S Rise, R Shiri-Sverdlov, G Hirsh Yechezkel, B Modan, MZ Papa, G Rechavi, E Friedman
Primary Institution: Chaim Sheba Medical Center
Hypothesis
Is there a novel BRCA1 mutation present in non-Ashkenazi Jewish families with ovarian cancer?
Conclusion
The study identified a novel BRCA1 mutation in two Jewish non-Ashkenazi families with ovarian cancer.
Supporting Evidence
- The novel mutation was confirmed by sequencing and a modified restriction digest assay.
- An identical haplotype was found in mutation carriers from two unrelated families.
- No mutation carrier was found among 118 unselected Jewish individuals of Iranian origin.
Takeaway
Scientists found a new change in a gene that can cause ovarian cancer in some Jewish families that are not from Eastern Europe.
Methodology
DNA was isolated from blood samples, and mutations were detected using PCR and protein truncation tests.
Potential Biases
There may be selection bias in the patients seen at the medical center.
Limitations
The sample size may be insufficient to detect the mutation in the general population.
Participant Demographics
Participants included 118 Jewish individuals of Persian origin, with a mix of men and women.
Want to read the original?
Access the complete publication on the publisher's website